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■ EDITORIAL ■
Menopause is defined as the cessation of ovarian func-
tion or of menstrual cycles. It is confirmed after 12
consecutive months without menses, or if the ovaries are
removed or damaged. It can also be confirmed by hor-
mone tests in women who have undergone hysterec-
tomy. The mean age at menopause is 49.3 years in
Taiwanese women [1]. The expected life span of
Taiwanese women is 78 years, and one-third of a
woman’s life, therefore, occurs after the menopause.
The number of women aged ≥50 years has increased
markedly in recent years, with an 87% increase over 16
years, from 1.74 million in 1992 to 3.25 million in 2008
(Figure) [2]. Although no accurate figure for the number
of menopausal women in Taiwan is available, it was
estimated to be around 3.25 million in 2008, with the
mean age of menopause close to 50 years. The registered
population in Taiwan in 2008 was 23.04 million.
Women aged ≥50 years, therefore, accounted for 14.0%
of the total population, or 28.4% of the total female
population.
The incidence of chronic diseases and comorbidities
increases markedly in menopausal women, and meno-
pausal status, as well as the aging process, plays an
important role in their development. It has been well
documented that reduced hormone levels accelerate
bone loss in postmenopausal women and, therefore,
increase the incidence of osteoporosis and bony frac-
tures [1]. The incidence of cardiovascular disease (CVD)
in younger women is much lower than that in men of the
same age, but the prevalence of hypertension and
coronary heart disease (CHD) in women aged ≥50 years
is higher than that in men [1].
Cerebrovascular accident, CHD and diabetes were
the second, third and fourth leading causes of death in
Taiwanese women in 2007, accounting for 10.0%, 9.8%
and 9.8% of all deaths, respectively [3]. Although
women have a greater life expectancy than men, the
prevalence of coronary artery disease is high in women
[4]. Care of menopausal women is thus an important
issue for health care institutions in Taiwan.
Metabolic Syndrome
Metabolic syndrome (MetS) represents a cluster of risk
factors for CVD, including atherogenic dyslipidemia,
elevated blood pressure, elevated glucose, a prothrom-
botic state, and a proinflammatory state [5]. People
with MetS are at high risk of diabetes and CHD and
suffer increased mortality from CVD [6,7]. MetS was
first defined in the Third Report of the National Cho-
lesterol Education Program Expert Panel on Detection,
Evaluation, and Treatment of High Blood Cholesterol in
Adults (Adult Treatment Panel III) [5]. Subsequent
studies have revealed ethnic difference in the develop-
ment of intra-abdominal fat accumulation and in the
risk of CVD. Asian races are more susceptible to intra-
abdominal fat accumulation and more susceptible to
CVD than Caucasians, even at a lower body mass index
[8,9]. The diagnostic cutoffs for MetS in the Adult
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Figure. Number of women aged > 50 years in Taiwan.
Treatment Panel III criteria were, therefore, modified to
account for these ethnic differences [8]. The definition
of MetS used in Taiwan is in accordance with the MetS
criteria for Taiwanese from the Bureau of Health Pro-
motion in Taiwan. The Table summarizes the diagnostic
criteria for MetS in Taiwanese patients [10].
The prevalence of MetS varies according to the
diagnostic criteria, population, age, sex, and area. The
prevalence of MetS among Taiwanese adults was 19.5%
in men and 13.8% in women in 2005, according to the
MetS criteria for Taiwanese [11]. However, there was 
a surge in the incidence of MetS in perimenopausal
and postmenopausal Taiwanese women, from 24.2%
in Taiwan metropolitan women aged 40–64 years, to
51.8% in women ≥ 65 years [12]. Methods for the
treatment and prevention of MetS in perimenopausal
and postmenopausal women are, therefore, urgently
required.
In addition to CVD, MetS is also highly associated
with non-alcoholic fatty liver disorders [13]. Non-
alcoholic fatty liver disorders, rather than hepatitis B,
are now the leading cause of abnormal liver function in
Taiwan [14].
Menopause and Components of MetS
Body composition
Two patterns of body fat distribution have been
observed; android or apple-shaped body composition
(central obesity) represents intra-abdominal fat accu-
mulation, while gynoid or pear-shaped composition
represents fat accumulation in the gluteofemoral region.
Central obesity with intra-abdominal fat deposition is
associated with a higher risk of diabetes, hypertension
and CVD [15]. For a 1-cm increase in abdominal cir-
cumference, the relative risk of a CVD event is increased
by 2% [16].
The menopausal transition accelerates intra-
abdominal fat accumulation, with a decrease in lean
body mass. These changes in body composition may be
attributed to the aging process, hormonal changes, or
changes in physical activity [16]. A study by Gambacciani
et al [17] revealed that menopausal transition, rather than
the aging process, contributed to intra-abdominal fat
accumulation in perimenopausal and postmenopausal
women. On the other hand, a study by Kanaley et al [18]
showed that the level of physical activity, but not men-
opausal state or age, accounted for intra-abdominal
fat accumulation in menopausal women. Chang et al
[19] reported that age, menopause and central obesity
were all independent and significant risk factors for
CVD in Chinese women.
These discrepancies in the results among different
studies probably reflect the complexity of the relation-
ship between menopausal status and body fat. Incon-
sistent conclusions may be due to ethnic bias or
different methodologies. Irrespective of the etiology of
intra-abdominal fat accumulation, the incidence an
abnormal waist circumference was shown to increase
dramatically in perimenopausal and postmenopausal
women in Taiwan; the incidence increased from 10.7%
in women aged 40–49 years to 22.8% in women aged
50–59 years, and to about 40% in women ≥ 65 years.
Insulin resistance
Insulin resistance is one of the most important patho-
physiologic components of MetS. However, the effect of
menopausal transition on insulin resistance remains
to be determined. Some studies revealed a decrease in
insulin sensitivity in postmenopausal women compared
with premenopausal women [20–22], but others failed
to find such a relationship [23,24]. Furthermore, the
aging process and changes in body fat distribution may
also contribute to a decrease in insulin sensitivity in
postmenopausal women.
DeNino et al [20] found a reduction in insulin sensi-
tivity only in older women > 60 years of age. Age-related
differences in visceral fat accumulation could explain
only a modest part of the decline in insulin sensitivity
in nonobese women. Otsuki et al [22] demonstrated that
menopausal state was associated with elevated fasting
plasma glucose. However, most previous studies were
based on indirect measurements of insulin sensitivity.
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Table. Diagnostic criteria for metabolic syndrome in Taiwanese adults in 2006
Measures Cut-off points
Increased waist circumference (central obesity) ≥ 90 cm in men, ≥ 80 cm in women
Elevated BP Systolic BP ≥ 130 mmHg or diastolic BP ≥ 85 mmHg, 
or drug treatment for hypertension
Reduced high-density lipoprotein-cholesterol Men: ≤ 40 mg/dL; women: ≤ 50 mg/dL
Elevated fasting glucose ≥ 90 mg/dL or drug treatment for elevated glucose
Elevated triglycerides ≥ 150 mg/dL
BP = blood pressure.
A recent study by Toth et al [24], using direct measure-
ment of insulin sensitivity (hyperinsulinemic–euglycemic
clamp technique), revealed that menopausal status did
not affect insulin sensitivity. Further studies are needed
to determine the relationship between menopausal
transition and insulin sensitivity.
An epidemiologic study by Lin et al [12] demon-
strated that the prevalence of high glucose levels was
11.6% and 34.1% in Taiwanese metropolitan women
aged 40–64 and ≥ 65 years, respectively. The study by
Chang et al [19] demonstrated that menopausal status
was an independent risk factor for glycosylated hemo-
globin A1c in Taiwanese women; menopausal women
had higher levels than premenopausal women.
Blood pressure
Premenopausal women usually have lower blood pres-
sure than age-matched men. The rise in systolic blood
pressure in postmenopausal women is steeper when
compared with that in men [25], which results in
marked increase in the prevalence of hypertension in
postmenopausal women. The mechanisms responsible
for rapid increases in blood pressure in postmenopausal
women may be related to hormone changes during
menopausal status and to other complex factors, includ-
ing a change in the estrogen to androgen ratios, acti-
vation of the rennin–angiotensin system, increased
endothelin levels, obesity, increased oxidative stress, and
a higher sympathetic activity [26]. However, the rela-
tionship between menopause and hypertension remains
controversial. Several studies revealed no relationship
between menopause and hypertension [27]. The rise
in systolic blood pressure does not occur during the
menopausal transition or immediately after menopause,
but rather develops over a number of years after meno-
pause [28]. These inconsistent results indicate the
complexity in the pathophysiology responsible for the
increases in systolic blood pressure in postmenopausal
women.
Although the systolic blood pressure increases with
advancing age, the mean diastolic blood pressure
decreases gradually from the sixth decade on [28].
Chow et al [1] found that postmenopausal women in
Taiwan had a higher systolic blood pressure and dias-
tolic blood pressure than age-matched men. However,
Torng et al [29] revealed that the increases in blood
pressure in postmenopausal women in Chin-Shan area
were not significant after being adjusted for age and
body mass index. The prevalence of abnormal blood
pressure (systolic pressure ≥130mmHg or diastolic pres-
sure ≥ 85 mmHg) in Taiwanese metropolitan women
aged 40–65 years and > 65 years was 44.2% and 84.1%,
respectively [12].
High-density lipoprotein cholesterol 
(HDL-C) and triglycerides
HDL-C has a protective effect on the cardiovascular
system. Previous studies have demonstrated an inverse
relationship between blood levels of HDL-C and the
incidence of CHD. Low blood levels of HDL-C are
associated with an increased risk of coronary artery
disease. The relative risk of coronary artery disease in
women with HDL-C < 40 mg/dL was comparable with
the relative risk of low-density lipoprotein cholesterol
(LDL-C) > 160 mg/dL. HDL-C is, therefore, a better
predictor of CHD than LDL-C [30].
Although some studies found that menopausal
women had significantly lower levels of HDL-C [31,32],
others showed an increase [31] or no change [22] in
HDL-C levels. Taiwanese women had significantly lower
LDL-C and higher HDL-C levels than Framingham
women [29,33,34]. The more favorable lipoprotein pro-
files in Taiwanese women may be attributed to lower
dietary total fat, saturated fatty acids and cholesterol,
and more dietary polyunsaturated fatty acids [35]. Thus,
the association between menopausal status and HDL-C
levels still remained to be determined. Several studies
have focused on the relationship between menopausal
status and HDL-C concentrations in Taiwanese women,
but the results have been inconsistent. A cohort study in
the Chin-Shan community, a rural area in North Taiwan,
failed to demonstrate any reduction in serum HDL-C
levels after menopause [29]. The study by Chang et al
[19] revealed that menopausal status was not an inde-
pendent risk factor for HDL-C levels in Taiwanese women
[19], while other reports have shown that postmeno-
pausal women in Taiwan had significantly higher HDL-C
levels than premenopausal women [29,33,34]. However,
the risk of low HDL-C levels in metropolitan Taiwanese
women increased with age, with a prevalence of 56.4%
in women aged 40–65 and 62.7% in those aged > 65
years [12]. These inconsistent results may reflect differ-
ences in lifestyles between different areas, as metropoli-
tan women tend to have a relatively sedentary lifestyle.
Previous studies in Taiwan demonstrated that meno-
pausal transition was associated with an increased
triglycerides level [19,29,33,34]. These results were con-
sistent with studies in other ethnic populations [32,34].
The prevalences of high triglycerides levels were 19.3%
and 33.2% in metropolitan Taiwanese women aged
40–65 and ≥ 65 years, retrospectively [12].
Lifestyle and MetS
Obesity and sedentary lifestyle are the most important
factors contributing to the development of MetS.
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Lifestyle intervention is, hence, the first and most impor-
tant strategy for its treatment. However, there have
been surprisingly few studies focusing on the effects of
lifestyle intervention on MetS, especially in menopausal
women. Previous studies have revealed that lifestyle
interventions with changes in diet and regular aerobic
exercise over periods of > 6 months could effectively
improve most components of MetS [36–38]. However,
these interventions had no significant effect on HDL-C
concentrations [36–38].
Regular aerobic exercise for > 6 months without
dietary intervention could significantly increase HDL-C
concentrations [39]. It is possible that the apparently
limited effect of lifestyle intervention on HDL-C may be
because dietary changes cause a decrease in HDL-C,
which cancels out the favorable effects of exercise.
A previous study in Taiwanese women revealed that
an 8-week lifestyle intervention program could signifi-
cantly improve four of the five components of MetS,
but that the HDL-C concentration was markedly re-
duced [40]. These results indicated that short-term
exercise programs could not improve HDL-C levels
enough to compensate for the detrimental effects of
dietary control. Lifestyle interventions for longer than
8 weeks are needed to clarify this relationship.
In addition to their effects on the components of
MetS, lifestyle interventions can also improve physical
fitness, insulin sensitivity, liver function, and quality of
life [40,41]. Adequate and regular aerobic exercise is
especially important for menopausal women. Rapid
loss of lean body mass, as well as rapid bone loss,
occurs during the perimenopausal period. Regular aer-
obic exercise may effectively prevent and treat MetS. In
addition, regular exercise may help to maintain lean
body mass in perimenopausal and postmenopausal
women, and prevent disability due to muscle wasting in
older women.
Conclusion
The prevalence of MetS has increased markedly in
Taiwanese menopausal women in recent years, especially
in metropolitan areas. The development of strategies for
preventing and treating MetS, together with the man-
agement of menopausal symptoms, osteoporosis and
cancer screening women, is becoming one of the most
important issues in the health care of menopausal. An
inappropriate lifestyle, including a lack of physical activ-
ity and excessive caloric intake, is the major contribu-
tor to MetS. Lifestyle interventions, therefore, provide
the key first step in the prevention and management of
MetS. Gynecologists in Taiwan play a major role in the
health care of menopausal women and, therefore, need
to increase their efforts to effectively manage MetS.
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